Today marks a significant step for Boehringer Ingelheim’s immuno-oncology pipeline by adding an innovative preclinical program with the acquisition of Nerio Therapeutics
Discover the reality of life with schizophrenia through the stories of people who are breaking down the stigma of living with a serious mental illness.